Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W J F M van der Velden
Reduced PTLD-related Mortality in Patients Experiencing EBV Infection Following Allo-SCT After the Introduction of a Protocol Incorporating Pre-Emptive Rituximab
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Pre-Transplant Diabetes Mellitus Is a Risk Factor for Non-Relapse Mortality, Especially Infection-Related Mortality, After Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Incidence of Epstein-Barr Virus (EBV) Detection in the Blood, Pre-Emptive Therapy, and EBV-Posttransplantation Lymphoproliferative Disorder (EBV-PTLD) After Allogeneic Hematopoietic Cell Transplantation (HCT) Across a Broad Range of HCT Approaches and All Graft Sources
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pre-Emptive Antiviral Therapy for Active CMV Infection in Adult Allo-SCT Patients Guided by Plasma CMV DNAemia Quantitation Using a Real-Time PCR Assay: Clinical Experience at a Single Center
Bone Marrow Transplantation
Transplantation
Hematology
Fatal H1N1 Influenza Infection in an Allo-SCT Recipient
Bone Marrow Transplantation
Transplantation
Hematology
Disease Status Is a More Reliable Predictive Factor Than Histology in Lymphoma Patients After Reduced-Intensity Conditioning Regimen and Allo-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Successful Management of Candida Krusei Monoarthritis After Allo-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Evidence for a GVL Effect Following Reduced-Intensity Allo-SCT in ALL: A British Society of Blood and Marrow Transplantation Study
Bone Marrow Transplantation
Transplantation
Hematology
Delay in B-Lymphocyte Recovery and Function Following Rituximab for EBV-associated Lymphoproliferative Disease Early Post-Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Pre-Emptive Immunotherapy With Purified Natural Killer Cells After Haploidentical SCT: A Prospective Phase II Study in Two Centers
Bone Marrow Transplantation
Transplantation
Hematology
